sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
DYN
Updated 10/6/2026, 8:56 AM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| DYN Dyne Therapeutics, Inc. | Sale | $25,408 | Friedl-Naderer Johanna Chief Commercial Officer | 1,085 sh | at $23.42 | Filed Sep 8, 4:15 PM ET | Filing | |
| DYN Dyne Therapeutics, Inc. | Sale | $115,546 | Kerr Douglas Chief Medical Officer | 5,035 sh | at $22.95 | Filed Sep 8, 4:14 PM ET | Filing | |
| DYN Dyne Therapeutics, Inc. | Sale | $106,823 | Cox John CEO & President, Director | 5,658 sh | at $18.88 | Filed Sep 8, 4:13 PM ET | Filing | |
| DYN Dyne Therapeutics, Inc. | Sale | $65,184,894 | Rhodes Jason P Director | 2,586,928 sh | at $25.20 | Filed Aug 17, 5:30 PM ET | Filing | |
| DYN Dyne Therapeutics, Inc. | Sale | $5,939 | Friedl-Naderer Johanna Chief Commercial Officer | 226 sh | at $26.28 | Filed Aug 17, 4:08 PM ET | Filing | |
| DYN Dyne Therapeutics, Inc. | Sale | $40,892 | Kerr Douglas Chief Medical Officer | 1,556 sh | at $26.28 | Filed Aug 17, 4:08 PM ET | Filing | |
| DYN Dyne Therapeutics, Inc. | Sale | $131,032 | Cox John CEO & President, Director | 4,986 sh | at $26.28 | Filed Aug 17, 4:07 PM ET | Filing | |
| DYN Dyne Therapeutics, Inc. | Sale | $47,225 | Lucera Erick Chief Financial Officer | 1,797 sh | at $26.28 | Filed Aug 17, 4:06 PM ET | Filing | |
| DYN Dyne Therapeutics, Inc. | Sale | $6,670,769 | Kersten Dirk Director | 261,460 sh | at $25.51 | Filed Jul 29, 4:15 PM ET | Filing | |
| DYN Dyne Therapeutics, Inc. | Sale | $17,858,492 | Rhodes Jason P Director | 777,451 sh | at $22.97 | Filed Jul 8, 5:35 PM ET | Filing |